Good morning everyone and welcome to eHealth Inc.'s Conference Call to discuss the Company's Second Quarter Financial Results. At this time, all participants have been placed in a listen-only mode. The floor will be opened for your questions following the prepared remarks. I will now turn the floor over to Eli Newbrun-Mintz, Senior Investor Relations Manager. Please go ahead.

Good morning and thank you all for joining us today. On the call today, Fran Soistman, eHealth's Chief Executive Officer and John Stelben, Chief Financial Officer, will discuss our second quarter 2024 financial results. Following these prepared remarks, we will open up the line for a Q&A session with industry analysts. As a reminder, this call is being recorded and webcast from the Investor Relations section of our website. A replay of the call will be available on our website later today. Today's press release, our historical financial news releases and our filings with the SEC are also available on our Investor Relations site. We will be making forward-looking statements on this call about certain matters that are based upon management's current beliefs and expectations relating to future events impacting the company and our future financial or operating performance. Forward-looking statements on this call represent eHealth's views as of today and actual results could differ materially. We undertake no obligation to publicly address or update any forward-looking statements except as required by law. The forward-looking statements we will be making during this call are subject to a number of uncertainties and risks, including but not limited to, those described in today's press release and in our most recent annual report on Form 10-K and our subsequent filings with the SEC. We will also be discussing certain non-GAAP financial measures on this call. Management's definitions of these non-GAAP measures and reconciliations to the most directly comparable GAAP financial measures are included in today's press release. With that, I'll turn the call over to Fran Soistman.

Thank you, Eli. Good morning and thank you to everyone joining us today. Before we dive deeper into the discussion of the second quarter, I wanted to address the news we announced last night. I will be retiring from my role as CEO by or before the second quarter of 2025 once a successor is on board. As you may recall, I came out of retirement three years ago to take on the CEO role in November of 2021. It has been a privilege to lead this company during this time. Since then, I am proud of the leadership team we've assembled during my tenure and the progress we have made transforming eHealth by creating a healthy and vibrant culture, evolving carrier relationships, enhancing focus on member retention and deploying new technologies to name a few. Over the past two years, we've achieved tremendous progress across key profitability metrics, including GAAP net income, adjusted EBITDA and operating cash flow. With the business on solid footing and advancing steadily towards our three-year growth and profitability goals, now is the right time to announce my intention to retire as CEO in 2025. There are a few reasons that I made the decision to inform the Board of my plans to retire. First, it was important for me to disclose this ahead of the start of the annual enrollment period on October 15. I will continue to oversee the AEP and OEP as I have always done in the past and intend to stay close to our consumers and carrier partners during this time. Importantly, I'm focused on continuing our work to position the business to achieve our long-term financial and operating goals, including enhancing eHealth's capital structure. Further, making this decision now provides the Board the time it needs to cast a broad net and thoughtfully evaluate both internal and external candidates. I have full confidence in the eHealth team and I look forward to continuing to serve on the eHealth Board and helping guide our accomplishments in the years to come. With that, I'll now cover some of the recent industry developments, our second quarter performance highlights as well as the important work we are doing in preparation for the upcoming annual enrollment period. eHealth delivered another quarter of strong execution and performance, including significant growth in application volume across our core agency model and carrier dedicated Amplify platform. Our existing book of business continued to generate positive tail revenue driven by favorable retention and cash collection trends. On the expense side, we continue to find savings within our fixed cost base and improved per-member acquisition costs in our Medicare Agency business compared to Q2 a year ago. Excluding tail revenue in both periods, second quarter revenue grew 13% year-over-year, accompanied by a significant improvement in adjusted EBITDA and earnings on the same basis. As we move into the second half of 2024, preparations for the AEP are now in full swing. We have begun training our new adviser classes, are adding innovative features to our consumer-facing online platform and are rolling out new customer retention strategies and capabilities. We also continue to fine-tune our brand-driven messaging and marketing materials, including new TV ads featuring eHealth spokesperson, Eve. As we approach this AEP, we continue to hear commentary from large carriers about their focus on Medicare margins amid regulatory and medical cost pressures. We expect for this trend to result in substantial changes to benefit packages, premiums, geographic coverage and other key planned strategies. It is also important to note that there remain several important meetings with our large carrier partners to learn more details about their 2025 planned strategies. In this fluid environment, I want to emphasize that eHealth's value proposition as a trusted adviser to beneficiaries and our omnichannel choice model are more relevant than ever. Combined with the continuing reduction in fulfillment capacity with two new competitor exits in the past few months, we believe this creates an opportunity to drive strong consumer demand to our platform during the enrollment season. The anticipated Medicare plan changes that I just described could have a substantial impact on beneficiaries. Considering this, I have personally sent a letter to CMS advocating for proactive steps to ensure seniors have adequate time to review their options, understand the modifications to their coverage and provider networks and find plans that best fit their needs. Combined with the distracting election season and the late Thanksgiving holiday this year, we believe CMS should consider extending the AEP or establishing an incremental special enrollment period. With respect to recent regulatory activity in our space, earlier this year, eHealth joined a lawsuit filed by the counsel for Medicare Choice, which resulted in a temporary stay on key broker compensation provisions of the CMS 2025 Medicare rule. While we believe that these provisions do not apply to our business, we view this as a positive outcome as it signals to CMS that it has overstepped its authority and potentially discourages them from doing so in the future. We believe the stay also helps avoid a wide range of interpretations of the rule by our carrier partners as they oversee compliance of their distribution channels based on their own interpretation of CMS regulations. Moving now to our second quarter operational overview. In our Medicare segment, hiring and training of our new licensed benefit advisor classes is progressing well. This year's hiring ramp is not as steep compared to last year. As we enter 2024 with a greater number of tenured advisers who will be staying on year round. We are targeting closer to a 50-50 mix of tenured versus newly hired benefit advisers for this AEP. This compares to approximately 30% tenured and 70% new advisers last year. This mix shift has positive implications for our conversion rates. Further, this year, we are supplementing our advisory capacity through the introduction of 1099 contracted licensed agents. As we prepare our organization for AEP, we continue to build on our brand initiatives and audience targeting strategies, leveraging important learnings from last year. This includes further emphasis on the channels and audiences that work best for us as well as the introduction of new partners and audiences such as the growing chronic special needs plans or C-SNPs population. Brand initiatives will again be front and center for our marketing organization. We believe our newly launched brand was a key differentiator last AEP, helping us gain immediate traction with beneficiaries who are typically inundated by repetitive, generic messages and saw our ads as a breath of fresh air. In year two of deployment, we expect our branded messaging to grow even more impactful across our direct channels as we reinforce our consumer-centric image as a remarkably transparent shop, educate, buy and enroll platform. On the product side, we continue to enhance user experience across our omnichannel platform. We are updating our plan comparison tools to include a more extensive needs analysis upfront and a simplified recommendation output aligned to customer-specific needs. We are also adding features that simplify saving application progress online, so the beneficiaries can return at their convenience to finish their enrollment. Our platform updates also have a particular focus on improving our mobile experience as we are observing an increased number of seniors engaging with our site using their smartphones and tablets. Further, in Q2, we expanded the pilot of our video enrollment tool, Live Advise, to additional benefit advisers. We have had encouraging anecdotal feedback on the product from both advisers and beneficiaries as a way to combine the convenience of a telephone enrollment with a personal touch of video interaction that helps build rapport and trust. We also expect this new capability to support our retention objectives by creating a more memorable experience and first impressions. Turning to execution highlights, our Medicare agency model delivered an outstanding second quarter, generating 9% year-over-year Medicare Advantage submission growth. This was driven by strong performance within our direct and affiliate marketing channels combined with an increase in telephonic conversion rates. Our agency choice model remains a core offering for eHealth as we strive to be the gold standard in health insurance distribution. Our ability to serve customers nationwide, supported by unbiased carrier-agnostic recommendations sets eHealth apart. We believe this differentiation will be especially valuable in this upcoming enrollment cycle. Moving now to Amplify; our carrier-dedicated model continues to scale. The second quarter saw strong enrollment volumes and conversion rates for our Amplify partners. We onboarded a new customer during the second quarter and have a robust pipeline of new partnerships, some of which we expect to launch ahead of this year's AEP. This is a small industry and the high level of service we provide to our partners and their customers is resonating with carriers, creating additional opportunities for us to grow. Amplify generated $4.1 million in total revenue in Q2 and was the largest driver behind the 37% year-over-year growth in our non-commission or other revenue. This serves as a strong testament to the success of our business diversification strategy. Putting a bow on the discussion of our agency and Amplify models, the two offerings provide a breadth of distribution services for our carrier partners. Our agency platform drives high volume, high-quality enrollments from beneficiaries who value choice, comparison shopping and omnichannel tools. This is a target market that carriers cannot reach through their internal direct-to-consumer sales. On the other side, Amplify augments carrier fulfillment organizations in an efficient and compliant manner which is critical in this highly regulated and seasonal industry. Both models offer carriers real-time insight into shopping and demand trends, what is important to consumers and planned selections and how their offerings track against competition by local market. Now I will turn to retention, including our key initiatives in this area. Across our book of MA business, we are seeing stable to slightly improved member retention which represents our ability to retain members on the eHealth platform regardless of whether they stay on the same plan or switch to a new one. Member level retention represents an increasingly important operational focus as we anticipate greater levels of planned shopping and switching this AEP. This year, we are rolling out several new retention initiatives. First, we introduced a new tool called Match monitor. This allows members to easily understand the implications of the annual notice of changes which carriers send out ahead of the AEP, check if any of their critical benefits are impacted and compare their current plans to other options in the area. Second, we continue to expand our loyalty program, ePerks, by adding new partners to the platform. This program is designed to provide value to our members beyond their health insurance coverage while building a stronger relationship with eHealth. Third, we recognize that the waiting period between an application and when a policy becomes effective can frequently be a source of anxiety. To address this, we're introducing eHealth application tracker, a tracking tool that displays to beneficiaries for real-time status of their applications as they progress from the initial sent phase to approval by carrier. Finally, we continue to support a dedicated retention team that serves our existing members and offers tailored programs for dual special need plans, or D-SNPs and other customer audiences identified as having elevated churn risk. Moving to our balance sheet; we continue to make progress with our advisers towards improving our capital structure. This continues to be one of our most important priorities this year and we recognize that our investors have great interest in seeing us achieve this objective. We believe we have more than sufficient liquidity to execute on our three-year plan and continue to target positive free cash flow generation for the trailing 12-month period ending March 2025. We also believe we are well-positioned to refinance or replace our Blue Torch term loan at equal or favorable rates before it becomes due early next year. Based on our strong performance year-to-date, we are raising our guidance ranges for Fiscal Year 2024, as John will discuss shortly. ORC is now underway to prepare our sales and marketing organization for what is expected to be a highly dynamic fourth quarter with significant consumer shopping. We expect to be in a strong position to take advantage of this opportunity. Before I turn the floor over to John Stelben to provide his remarks, I would like to comment on the CFO transition process underway. This is John Stelben's last earnings call and I want to publicly acknowledge his important contributions to this organization. John came out of retirement two years ago to help implement our business transformation plan. It brought new and important financial rigor and discipline that has greatly contributed to the operational and financial progress we've achieved over the past two years. It's been a pleasure and a privilege to have worked with John for more than 25 years and I wish him all the best as he re-enters retirement. As we previously shared with you, John Dolan, who is currently eHealth's Chief Accounting Officer, will be succeeding John Stelben as our CFO effective August 31. The transition is going beautifully as anticipated and I have great confidence that John Dolan's leadership will be instrumental in sustaining the momentum of our financial performance. With that, I will turn the call over to John Stelben for financial remarks.

Thank you, Fran. Second quarter results were driven by strong execution in our Medicare segment and continued operating cost discipline across our organization. Based on our financial performance year-to-date, we are increasing our 2024 annual guidance ranges. Across our agency choice and carrier dedicated platforms, eHealth drove a 16% increase in Medicare submissions year-over-year. Some of that volume is reflected in our approved membership metrics, while enrollments transacted under fee-based arrangements within Amplify, our carrier dedicated platform, flow through our non-commission or other revenue which grew 37% year-over-year. I will elaborate on this in just a moment. Total second quarter revenue was $65.9 million, a decline of 1% year-over-year. Tail revenue across all products was $11.5 million which compares to $18.7 million in Q2 of last year. Excluding tail, total revenue for the quarter increased 13% year-over-year. Our Medicare segment generated $59.2 million in revenue, an increase of 7% compared to the second quarter of 2023. During the quarter, we recognized $10.7 million in positive net adjustment or tail revenue from our Medicare segment compared to $13.4 million a year ago. Excluding tail, Medicare revenue grew 16% year-over-year. Second quarter Medicare segment profit of $1.3 million improved from segment loss of $2.1 million last year as we scale Medicare revenue and improve member economics. Excluding the impact of tail revenue, Medicare segment loss improved by $6.1 million year-over-year. Turning to Medicare enrollment. Last year, we launched our carrier dedicated fulfillment platform Amplify. During the second quarter, we started to shift some of the Amplify arrangements that were structured as broker of record, LTV-based enrollments, to fee-based BPO arrangements. With BPO arrangements, eHealth does not become a broker of record and instead gets paid a combination of base compensation to cover call center costs and conversion success fees upfront, which improved the timing of our cash flow. During this transition period, we will provide a view into submitted applications across both platforms which we define as an application sent by eHealth to a carrier regardless of whether it comes from our agency choice or Amplify fulfillment model. As more Amplified partnerships transition to fee-based arrangements, our success there can be best measured through growth of non-commission revenue. Total second quarter Medicare submissions grew 16%, including 17% growth for the Medicare Advantage plans, 25% growth for Med Supp and a 4.9% decline for prescription drug plans. Separating only commission-based enrollments, including our agency model and those amplified partnerships where we still operate as a broker of record, Medicare submissions increased 5% year-over-year, including 12% growth in MA submission. Medicare supplement submissions declined 44% year-over-year, reflecting a shift of a major Med Supp partner to a BPO model. Q2 Medicare Advantage lifetime value of 927 increased 4% year-over-year, reflective of continued improvement in commission payments per approved member, as well as a reduction from 7% to 5.5% and constraint that we apply to estimated lifetime commissions for these plans. As you know, we recognize revenue for our commission-based products in accordance with U.S. GAAP under ASC 606, where we record our initial revenue in a manner that makes significant negative reversals in future periods not probable. In order to satisfy that guideline, we, among other factors, apply a constraint to our LTVs generated by our actuarial models. During the second quarter, we performed our annual constraint review for all commission-based products. Our analysis concluded that we could reduce the constraint for Medicare Advantage products. This analysis produced a range of potential outcomes and the decrease to 5.5% from 7% is at the more conservative end of the range that this process yielded. We believe this revision constraint reflects improvements in our revenue recognition process and will continue to produce initial revenue estimates that satisfy the requirements of ASC 606. Long term, we expect this change to bring our initial revenue recognition more in line with the lifetime cash collections of our MA approved members and reduce the amount of adjustment revenue we recognize in future periods. Turning to Medicare member retention. Q2 is the most important quarter for understanding retention trends in our book of business following the key enrollment and switching periods, AEP and OEP. Ultimately, our goal is to increase member persistency on our platform regardless of whether a beneficiary remains on the same policy or switches plans as their needs evolve. Overall retention across all Medicare Advantage member cohorts improved slightly for the trailing 12 months ended 6/30 compared to the trailing 12-month period ended 6/30/2023. In addition to the broader market dynamics and our proactive retention efforts that Fran described earlier, our marketing channel mix also has an impact on our retention. For example, we are observing a trend of retention improvement from our direct branded channels. This could be an early indicator of the positive impact of our brand strategies. Total acquisition costs per approved Medicare member improved 4% year-over-year, in line with our expectations. As a reminder, second and third quarters are characterized by higher variable costs per approved member relative to Q4 and Q1 as we start to prepare our sales and marketing organizations for the upcoming annual enrollment period. This investment is spread over seasonally low enrollment volumes in Q2, but we expect it will yield an attractive return for us later in the year. Member level metrics we provide, including acquisition cost per member, excludes submissions and associated costs under our BPO model where eHealth is not the broker of record. With respect to our employer individual segment, second quarter revenue was $6.6 million with segment profit of $900,000. This compares to segment revenue of $11.3 million and segment profit of $6.9 million in Q2 2023. One of the main drivers of the year-over-year decrease in segment revenue and profit was the decline in tail revenue of $4.5 million year-over-year. Enrollment volumes also declined year-over-year, partially offset by greater LTVs in qualified individual health plans, ancillary and small business products. Excluding tail, revenue was down 4% year-over-year and segment profitability decreased by $1.5 million. Recall from the Q1 earnings call, similar to the Medicare transformation begun in Q2 of 2022, we are taking the same approach to our employer individual business with a goal of returning to growth in Q4 of 2024. Moving to our fixed costs; non-GAAP TNC decreased 8% and non-GAAP G&A decreased 10%. These year-over-year savings were driven by our disciplined approach to expense management. Fixed cost leverage is expected to be one of the several key drivers for adjusted EBITDA growth over the next three years as we scale our business. On the GAAP side, Q2 reflects $3 million in restructuring and impairment charges. This includes $1.9 million in lease impairments as we continue to reduce our physical footprint as part of our remote first strategy as well as $1.1 million in severance costs related to personnel reductions. On a consolidated basis, second quarter GAAP net loss of $28 million compared to a loss of $23.5 million a year ago and adjusted EBITDA of negative $15.5 million compares to a negative $14.8 million in Q2 of 2023. Excluding the impact of restructuring and impairment charges and tail, net loss improved by $3.4 million and adjusted EBITDA improved $6.5 million on a year-over-year basis. Operating cash flow was negative $32.2 million compared to negative $9.4 million in Q2 2023. Change in cash flow was primarily driven by higher payouts of previously accrued performance bonus relative to what was accrued in 2022 and paid in 2023 as well as timing related to deferred revenue. Recall that in Q1, our deferred revenue was up over $8 million versus the prior year quarter. After achieving positive operating cash flow for the trailing 12 month ended March 2024, we continue to target positive free cash flow for the trailing 12-month period ending March 2025. eHealth ended the quarter with $151.1 million in cash, cash equivalents and marketable securities on our balance sheet. Our combined short- and long-term commissions receivable balance of $831.9 million, as of June 30 of this year compared to $789.6 million as of June 30, 2023. Total cash collections, including commission and non-commission are up $15.7 million on a year-to-date basis compared to the same period a year ago. Commission cash collections continue to exceed initial estimates, resulting in cumulative tail revenue and related contract asset increase of $215 million since 2018. Going forward, as amplified fee-based enrollments become a larger proportion of our enrollment mix, we will be adding fewer dollars to our commission receivable line item while at the same time, taking advantage of a more favorable cash flow profile of these arrangements. Moving now to our 2024 outlook. We are raising our guidance ranges to reflect strong performance and greater tail revenue year-to-date. As is our typical approach to guidance, we are not making any changes to our underlying expectations for the rest of the year, given the significant impact of the eight weeks of the AEP on the overall financial results. We see a significant opportunity ahead of us this enrollment cycle with favorable industry dynamics underway as described by Fran. We feel confident about our progress in preparing the organization for this important selling season. We are reserving the option to reinvest some of our expected revenue upside during this AEP given unique opportunities this macro environment might offer. As a result, we are increasing our adjusted EBITDA ranges by a lower amount relative to revenue. Our new guidance ranges are as follows: Total revenue for 2024 is now expected to be in the range of $470 million to $495 million compared to our prior guidance range of $450 million to $475 million. GAAP net loss for 2024 is now expected to be in the range of negative $36.5 million to negative $22 million compared to our prior guidance of negative $40 million to negative $20 million. Adjusted EBITDA for 2024 is now expected to be in the range of $7.5 million to $25 million compared to our prior guidance range of negative $5 million to positive $20 million. Operating cash flow for 2024 is now expected to be in the range of negative $10 million to break even compared to our prior guidance range of negative $15 million to negative $5 million. With respect to tail revenue, initial guidance for 2024 included a range of $0 million to $15 million. As of June 30, 2024, we have recognized $14 million of tail which is near the high end of our range. While we cannot predict future tail with certainty, it is fair to project we could see another $0 million to $6 million of tail recognized in the back half of the year. As such, we are updating the range for total 2024 positive net adjustment revenue to be between $14 million and $20 million. Looking ahead to Q3, excluding tail revenue, we expect revenue to grow in the mid-single-digit percentage range and for adjusted EBITDA to also improve in the mid-single-digit percentage range as we continue to ramp up our adviser force and make other preparations for the AEP. As eHealth moves into the critical second half of the year, we are doing so from a position of strength and preparedness. I am proud of the tremendous progress this company achieved in the past two years and the management team Fran brought together. As this will be my final earnings call with eHealth, I will add that I'm also completely confident in our incoming CFO, John Dolan's ability to continue to lead our finance organization and support the strategic plan. He brings a wealth of financial expertise and leadership ability that sets him up well to be a successful CFO through this transition and beyond. He is on the call this morning and will be participating in Q&A. I would also like to thank all my finance colleagues for their support and results during my tenure at eHealth.

Gentlemen, thank you for your remarks. We'll hear first from George Sutton at Craig-Hallum.

Fran and John, congrats on your moves. They say AEP seasons are like dog years. So I think we've all proven that. So, I wanted to talk, Fran, if we could, about the political spend within the context of how you're going to go to market this AEP. Obviously, there typically will be a bit of a crowding out of marketing dollars. How do you shift your budgets to try to deal with that? And have you gotten any feedback from your letters to CMS to really encourage a longer shopping season?

Thank you. Let me address the first question about the national election. We've encountered this situation before and have reviewed how it unfolded four years ago. Our omnichannel capabilities allow us to utilize various channels for each beneficiary. Enrollment volumes tend to be lower during the initial weeks of the annual enrollment period due to the national election, but then they pick up. Therefore, we plan to allocate more resources to direct mail, search engine optimization, search engine marketing, paid search, and other channels that are generally less impacted by the election compared to television advertising. Regarding my interactions with the Centers for Medicare & Medicaid Services, I have communicated with them twice on this issue. They have acknowledged the challenges I mentioned, including an increase in shopping this year, the timing of the national election, and Thanksgiving being late in November, with the enrollment period ending on a Saturday. All these factors will create additional challenges for beneficiaries. Therefore, extending the enrollment period by five or six days makes sense. However, we can't extend it too much beyond that since carriers need to distribute ID cards before January 1. This creates a natural deadline to prevent any unintended consequences. CMS has listened and recognized the situation, but it's unclear if they will take action. I will continue to advocate for this, and I will be releasing a statement in the coming weeks urging prompt action.

Good luck with that. I'm curious, John, you mentioned that you reserve the right to reinvest some upside from this AEP. Are you suggesting that you anticipate significant shopping activity and want to be prepared with potentially more marketing dollars to capitalize on that? Is that what you're indicating?

Yes, depending on how this AEP develops, we might see acquisition costs increase because of factors you mentioned in your earlier question. As a company, we intend to remain flexible and take advantage of opportunities in various channels. We evaluate our spending in these channels based on the lifetime value to tax or POAs. There is a chance we could experience profitable growth in channels with a slightly lower yet still favorable lifetime value to cash. The earnings in the fourth quarter can be several times greater than our annual earnings, so we plan to stay agile and ready. We're aiming to provide guidance that reflects a range of profitable growth opportunities.

Understand. Okay. John, it's been good to work with you.

Next, we'll hear from George Hill with Deutsche Bank.

Fran, I wanted to wish you well and appreciate you taking the question. I missed a good portion of the prepared commentary during this busy earnings morning. I was curious if you could share your thoughts on the expected churn for the 2025 AEP. Many Medicare plans are discussing significant market disruption, with some predicting high single-digit to low double-digit member attrition. How do you plan to address this, and how do you see opportunities for gaining market share in what appears to be a volatile market coming up in October?

Thanks for the good wishes and thanks for the question. We have made retention one of our key strategic priorities and work was underway 18 months ago to start that journey. We're making good progress. The introduction of a loyalty program. We've got special initiatives around the annual notice of changes in being proactive and helping beneficiaries navigate that. We have new tools that I think are going to be very helpful to address what will likely be a large demand for shopping this year. So protecting the book is critically important. No one is confused about that here at eHealth. So proactivity is the key. We do think there's an opportunity to grow share. A combination of capacity lowering in our industry and we think we're going to see significantly more shopping this year. There will be market exits which are typically disruptive but opportunistic for us to make sure that beneficiaries have a soft landing with an alternative plan. So we're all over it. I don't want to understate the importance; you're absolutely right, retention is critical. But I also feel confident in the strategies and the tools that we develop to prepare for this event.

It appears we have no signals from our phone audience. I am pleased to turn the floor back to Mr. Soistman for any additional or closing remarks.

Thank you, operator. Thank you, again, everyone. I know it's a busy morning for you all. Appreciate your participation. I appreciate the continued interest in eHealth. You've heard today, evidence of strong momentum that started multiple quarters ago and continues to this day. The energy level and the intensity of our focus for a successful AEP is great; and I remain confident that we'll be prepared for the opportunities that lie ahead. So, thank you once again.

Ladies and gentlemen, this does conclude today's teleconference and we thank you all for your participation. You may now disconnect your lines.